Does BRIGATINIB Cause Lung neoplasm malignant? 216 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 216 reports of Lung neoplasm malignant have been filed in association with BRIGATINIB (Alunbrig). This represents 6.6% of all adverse event reports for BRIGATINIB.
216
Reports of Lung neoplasm malignant with BRIGATINIB
6.6%
of all BRIGATINIB reports
38
Deaths
36
Hospitalizations
How Dangerous Is Lung neoplasm malignant From BRIGATINIB?
Of the 216 reports, 38 (17.6%) resulted in death, 36 (16.7%) required hospitalization, and 4 (1.9%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BRIGATINIB. However, 216 reports have been filed with the FAERS database.
What Other Side Effects Does BRIGATINIB Cause?
Death (405)
Non-small cell lung cancer (370)
Off label use (256)
Diarrhoea (239)
Metastases to central nervous system (219)
Nausea (218)
Fatigue (201)
Blood creatine phosphokinase increased (198)
Product dose omission issue (193)
Neoplasm progression (172)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which BRIGATINIB Alternatives Have Lower Lung neoplasm malignant Risk?
BRIGATINIB vs BRILINTA
BRIGATINIB vs BRILIQUE
BRIGATINIB vs BRIMONIDINE
BRIGATINIB vs BRIMONIDINE\BRINZOLAMIDE
BRIGATINIB vs BRIMONIDINE\TIMOLOL